Kieckhefer Group LLC Boosts Stock Holdings in Intuitive Surgical, Inc. $ISRG

Kieckhefer Group LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,540 shares of the medical equipment provider’s stock after buying an additional 3,700 shares during the period. Intuitive Surgical comprises approximately 3.0% of Kieckhefer Group LLC’s investment portfolio, making the stock its 6th biggest position. Kieckhefer Group LLC’s holdings in Intuitive Surgical were worth $6,503,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the business. Norway Savings Bank grew its holdings in shares of Intuitive Surgical by 53.4% in the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after purchasing an additional 910 shares during the last quarter. Trust Co. of Oklahoma bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at $363,000. IronOak Wealth LLC. purchased a new stake in Intuitive Surgical in the second quarter worth about $1,099,000. Amalgamated Bank raised its holdings in Intuitive Surgical by 2.2% during the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after acquiring an additional 1,772 shares during the period. Finally, Eastover Investment Advisors LLC increased its holdings in Intuitive Surgical by 204.8% in the 2nd quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after acquiring an additional 8,844 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the sale, the insider directly owned 27,027 shares in the company, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. This represents a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $575.40 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The business has a 50 day moving average price of $557.87 and a 200 day moving average price of $507.44. The company has a market capitalization of $206.27 billion, a P/E ratio of 76.11, a P/E/G ratio of 5.28 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the firm earned $1.84 earnings per share. The business’s revenue was up 22.9% on a year-over-year basis. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. Rothschild & Co Redburn raised their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. BTIG Research lifted their price target on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Finally, Royal Bank Of Canada lifted their target price on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $611.08.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.